{"name": "Spring Bank Pharmaceuticals",
 "permalink": "spring-bank-pharmaceuticals",
 "crunchbase_url": "http://www.crunchbase.com/company/spring-bank-pharmaceuticals",
 "homepage_url": "http://www.springbankpharm.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "info@springbankpharm.com",
 "phone_number": "508-473-5993",
 "description": "",
 "created_at": "Fri May 06 03:26:06 UTC 2011",
 "updated_at": "Fri May 06 03:32:46 UTC 2011",
 "overview": "\u003Cp\u003ESpring Bank Pharmaceuticals is an IND-stage drug discovery company. Based on their proprietary platform technology, they are developing a pipeline of products representing a new class of pharmaceuticals they call small molecule nucleic acid hybrids \u00e2\u20ac\u0153SMNH\u00e2\u20ac\u009d with a wide range of applications and multi-billion dollar market potential.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       29],
      "assets/images/resized/0013/3446/133446v1-max-150x150.jpg"],
     [[250,
       49],
      "assets/images/resized/0013/3446/133446v1-max-250x250.jpg"],
     [[450,
       89],
      "assets/images/resized/0013/3446/133446v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$3.9M",
 "funding_rounds":
  [{"round_code": "grant",
    "source_url": "http://www.masshightech.com/stories/2011/05/02/daily53-Spring-Bank-Pharma-wins-39M-NIH-grant-to-fight-Hep-B.html",
    "source_description": "Spring Bank Pharma wins $3.9M NIH grant to fight Hep B",
    "raised_amount": 3900000.0,
    "raised_currency_code": "USD",
    "funded_year": 2011,
    "funded_month": 5,
    "funded_day": 5,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "National Institutes of Health",
         "permalink": "national-institutes-of-health",
         "image":
          {"available_sizes":
            [[[150,
               23],
              "assets/images/resized/0025/4340/254340v1-max-150x150.png"],
             [[250,
               38],
              "assets/images/resized/0025/4340/254340v1-max-250x250.png"],
             [[391,
               60],
              "assets/images/resized/0025/4340/254340v1-max-450x450.png"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "113 Cedar Street, Ste S-7",
    "address2": "",
    "zip_code": "01757",
    "city": "Milford",
    "state_code": "MA",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        117],
       "assets/images/resized/0013/3447/133447v1-max-150x150.jpg"],
      [[250,
        195],
       "assets/images/resized/0013/3447/133447v1-max-250x250.jpg"],
      [[450,
        351],
       "assets/images/resized/0013/3447/133447v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}